Clinical Trials

Other hematologic neoplasm

20 enrolled

Hematologic Neoplasms

NCT07437820 2026-03-04

NeoSRS

Phase 2/3 Not yet recruiting

68 enrolled

CNS

Brain Neoplasms

NCT07426055 2026-02-23

PRO-BOOST-LC

1,200 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07414992 2026-02-17

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

44 enrolled

Urinary Bladder Neoplasms

NCT07393867 2026-02-06

ARPEGGIO

23 enrolled

Phase 3 Not yet recruiting

Prostatic Neoplasms

NCT07381660 2026-02-02

SBRT Versus Surgical Resection for Small HCC

312 enrolled

Carcinoma, Hepatocellular

NCT07379398 2026-01-30

Iparomlimab and Tuvonralimab Injection Combined With SBRT in Patients With Early-Stage Non-Small Cell Lung Cancer

28 enrolled

NSCLC

NCT07126158 2026-01-05

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

36 enrolled

Pancreatic Neoplasms

NCT07309952 2025-12-30

SACTION 2501

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07285538 2025-12-16

SBRTRC

60 enrolled

Kidney Neoplasms

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Phase 1 Not yet recruiting

Lung Neoplasms

NCT07075120 2025-10-28

Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer

15 enrolled

Carcinoma, Hepatocellular

NCT07189598 2025-09-24

ORION

390 enrolled

Prostatic Neoplasms

NCT07173387 2025-09-15

RAD-NALIRIFOX

42 enrolled

Pancreatic Neoplasms

NCT07152067 2025-09-03

TOPPGUN-RS

146 enrolled

Prostatic Neoplasms

NCT07132073 2025-08-27

MRI-guided Locoregional SBRT Prostate Program

40 enrolled

Prostatic Neoplasms

NCT07030140 2025-06-22

Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma

38 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms, Cholangiocarcinoma, Klatskin Tumor

NCT07007728 2025-06-06

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

54 enrolled

Colorectal Neoplasms

NCT06991491 2025-05-28

Ivonescimab With GnP and SBRT in Patients With Metastatic Pancreatic Cancer (WGOG-PAN 004)

29 enrolled

Phase 2/3 Not yet recruiting

Pancreatic Neoplasms

NCT06977061 2025-05-16

Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression

30 enrolled

Stomach Neoplasms

NCT05578274 2024-12-10

Abscopal Effect from Low-dose Radiotherapy in Metastatic Cancer Combined with Stereotactic Body Radiotherapy

186 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms, Neoplasms, Second Primary

NCT06592612 2024-09-19

Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

70 enrolled

Carcinoma, Hepatocellular

NCT06363773 2024-08-28

RESTO-IMMUNO

35 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06573398 2024-08-27

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

20 enrolled

Phase 1 Not yet recruiting

Carcinoma, Pancreatic Ductal

NCT06558175 2024-08-16

REPAIR

48 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

NCT06489821 2024-07-08

STAR-B

36 enrolled

Breast

Breast Neoplasms

NCT04571762 2024-05-23

Adaptive MR-guided SBRT for Localized Prostate Cancer

12 enrolled

Prostatic Neoplasms

NCT06422156 2024-05-20

Nim-PC-28

73 enrolled

Advanced Pancreatic Cancer

NCT06391008 2024-04-30

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

44 enrolled

Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

96 enrolled

Locally Advanced Pancreatic Cancer

NCT05998993 2023-08-21

CULTRO

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05808790 2023-04-11

COPPER

394 enrolled

Lung Metastases

NCT05747716 2023-02-28

SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC

44 enrolled

Colorectal Neoplasms

NCT05602974 2023-02-17

Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

140 enrolled